Related Experiment Videos
Selective neonatal BCG vaccination.
Acta Paediatrica (Oslo, Norway : 1992)
|September 24, 2004
Summary
The neonatal BCG immunization policy showed high effectiveness, with 85% of eligible newborns receiving the vaccine in the hospital. Infants not immunized at birth rarely receive the BCG vaccine later.
Area of Science:
- Public Health
- Immunology
- Pediatrics
Background:
- The implementation of selective neonatal BCG immunization policies is crucial for disease prevention.
- Understanding vaccine uptake and compliance is essential for public health strategies.
Purpose of the Study:
- To evaluate the effectiveness of the "Selective Neonatal BCG Immunisation Policy."
- To identify reasons for non-compliance or failure in BCG vaccine uptake among newborns.
Main Methods:
- Utilized Birth Register data to identify eligible neonates within Basildon and Thurrock NHS Trust (2001).
- Employed Community Child Health computer records to determine BCG immunization status.
Main Results:
- The study included 201 neonates eligible for BCG immunization.
- A high uptake rate of 85% was observed, with 171 neonates receiving BCG in the neonatal period.
- Most vaccinations (169) occurred before hospital discharge; only 2 occurred in the community.
Conclusions:
- The "Neonatal BCG Immunisation Policy" is effective in achieving high in-hospital vaccination rates.
- Neonates not immunized in the hospital setting have a low likelihood of receiving the BCG vaccine in the community.